Welcome to PsorVal.net | DermaSolve.net !

 

Your Source for Psor-Val | DermaSolve | Absorbase

 

 Serving Treatment Solutions for Psoriasis, Eczema, Dry Skin 

 

Providing News, Views, Tips and Tricks

along with great products for that   "Healthy You" 

 

Looking for Psor-Val Spray? Click here 


*Buy Psor-Val on Amazon* Click here


 

Now Shipping Psor-Val Spray World Wide

 International Clients - Click "We Ship Worldwide!"

MedWorm: Psoriasis

Treatment of two patients with generalized pustular psoriasis with the interleukin‐1β inhibitor gevokizumab (Sun, 19 Apr 2015)
Summary Generalized pustular psoriasis (GPP) is a severe, potentially life‐threatening inflammatory dermatosis, which is traditionally difficult to manage. Recent evidence suggests that interleukin (IL)‐1 plays a central role in the disease pathogenesis, and thus makes the use of IL‐1 inhibitors potentially effective. Two patients with severe, recalcitrant GPP were enrolled in an open‐label, expanded access study to receive a new IL‐1β inhibitor, gevokizumab. The two patients had a respective 79% and 65% reduction in GPP area and severity index scores at weeks 4 and 12, with some improvements in quality‐of‐life instruments. There were no significant adverse events related to the study medication, although one patient developed an abscess in a haematoma secondary to an injury... MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
>> read more

Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases (Sat, 18 Apr 2015)
Many case reports have described the coexistence of autoimmune bullous diseases (AIBDs) and psoriasis. Among them, anti-laminin γ1 (p200) pemphigoid is the best known. (Source: Journal of the American Academy of Dermatology)
>> read more

Serum prolactin levels in dermatological diseases: A case control study (Sat, 18 Apr 2015)
Conclusions Prolactin may play a role in the pathogenesis of alopecia areata, psoriasis, and vitiligo; and may serve as a biological marker of disease activity in patients with psoriasis and alopecia areata. (Source: Journal of Dermatology and Dermatologic Surgery)
>> read more

New psoriatic arthritis screening tool passes initial validation (Fri, 17 Apr 2015)
The second version of the Toronto Psoriatic Arthritis screen performed well at identifying psoriatic arthritis in 336 psoriasis patients, 131 psoriatic arthritis patients, and 89 individuals in the general population, according to Dr. Brian Tom and his associates. The sensitivities of the capped... (Source: Skin and Allergy News)
>> read more

Psoriatic arthritis associated with heavy drinking (Fri, 17 Apr 2015)
Heavy alcohol consumption was associated with incident psoriatic arthritis in women, Shaowei Wu, Ph.D., and his associates reported in a study of 116,430 female registered nurses in the Nurses’ Health Study II. The investigators found 141 incident cases of psoriatic arthritis (PsA) during... (Source: Skin and Allergy News)
>> read more

Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE) (Fri, 17 Apr 2015)
Conclusion In this heterogeneous Brazilian series of SpA patients, BASDAI was able to demonstrate “disease activity” in patients with axial as well as peripheral disease. (Source: Revista Brasileira de Reumatologia) MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
>> read more

Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice (Fri, 17 Apr 2015)
Journal of Dermatological Treatment, Ahead of Print. (Source: Journal of Dermatological Treatment)
>> read more

Clinical symptoms and self-reported disease severity among patients with psoriasis – Implications for psoriasis management (Fri, 17 Apr 2015)
Journal of Dermatological Treatment, Ahead of Print. (Source: Journal of Dermatological Treatment)
>> read more

Evidence-based adverse effects of biologic agents in the treatment of moderate-to-severe psoriasis: Providing clarity to an opaque topic (Fri, 17 Apr 2015)
Journal of Dermatological Treatment, Ahead of Print. (Source: Journal of Dermatological Treatment)
>> read more

Obesity and the metabolic syndrome in pediatric psoriasis (Fri, 17 Apr 2015)
Psoriasis is a common, chronic inflammatory dermatosis that often has its onset during childhood. There is increasing evidence that psoriasis in adults is associated with obesity, the metabolic syndrome, and associated comorbidities, including insulin resistance/type 2 diabetes, dyslipidemia, hypertension, and cardiovascular disease. This association is postulated to arise, at least in part, as a result of a systemic proinflammatory state that is mediated by adipose tissue. Several recent observational studies suggest that children and adolescents with psoriasis may be at increased risk of being overweight and obese as well as having an increased risk for features of the metabolic syndrome. (Source: Clinics in Dermatology)
>> read more

 

Scan our QR Code to your Smart Phone / iPhone Users download QR Reader from Tap Media http://www.TapMedia.co.uk 

Real Time Web Analytics


International Clients, After adding products to Cart - Refresh your browser if you do not see the "International Checkout" Button

Psor-Val Zinc Spray, DermaSolve Psoriasis Care Products and

Absorbase Cream for Moisturizing Skin Care.

 

Treatment Solutions and Products for Psoriasis, Eczema, Dry Skin. Natural Care for that Healthy You!